11,595
Total Claims
$1.7M
Drug Cost
2,570
Beneficiaries
$659
Cost/Patient
Peer Comparison vs. 109,535 Physician Assistant providers
-8%
Cost per patient vs peers
$659 vs $719 avg
+142%
Brand preference vs peers
16.1% vs 6.7% avg
Brand vs Generic
84% generic
Brand: 1,867 claims · $1.5M
Generic: 9,728 claims · $193K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 834 | $782K |
| Sacubitril/Valsartan | 237 | $242K |
| Rivaroxaban | 257 | $225K |
| Evolocumab | 66 | $51K |
| Ticagrelor | 87 | $50K |
| Empagliflozin | 45 | $39K |
| Dapagliflozin Propanediol | 43 | $30K |
| Alirocumab | 30 | $22K |
| Metoprolol Succinate | 1,142 | $19K |
| Evolocumab | 19 | $17K |
| Ranolazine | 104 | $16K |
| Icosapent Ethyl | 20 | $11K |
| Dabigatran Etexilate Mesylate | 15 | $9,832 |
| Diltiazem Hcl | 186 | $8,472 |
| Clopidogrel Bisulfate | 668 | $8,265 |
Prescribing Profile
65
Unique Drugs
$1.3M
Patient Profile
72
Avg Age
50%
Female
1.57
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data